NEWS

Watch the COVI-LINNC worldwide roundtable!

Multiple aneurysms - Who is the culprit?

Cerus Endovascular Receives CE Mark Approval for its 021 Contour Neurova...

FREMONT, Calif. and OXFORD, England, April 29, 2020 /PRNewswire/ -- Cerus Endovascular Ltd., a privately-held, commercial stage medical device company, today announced that it has received CE Mark approval for its 021 Contour Neurovascular System™, compatible with smaller commercially available 021 microcatheters for the treatment of saccular intracranial aneurysms. The Contour Neurovascular System™ is a unique, fine mesh braid that is deployed across the neck of the aneurysm sac and provides a combination of flow diversion and flow disruption through a single device implant. This new, lower profile system will allow physicians to access more distally challenging vascular anatomies.

Phenox GmbH launches p64 MW Flow Modulation Device with HPC coating tech...

Bochum, Germany – 27 April 2020 - Phenox GmbH, a pioneer of innovative technologies for neurovascular diseases, has announced the European launch of the new p64 MW Flow Modulation Device. The device received CE mark in January 2020 and is available with the proprietary HPC surface modification, a new technology which could revolutionize patient care in vascular intervention. 

Left MCA M1 Occlusion treated with STAT technique

Cerus Endovascular Receives CE Mark Approvals for its Neqstent™ Coil Ass...

Fremont, California and Oxford, United Kingdom April 22, 2020 – Cerus Endovascular Ltd., a privately-held, commercial stage medical device company, today announced that it has received CE Mark approval for its Neqstent™  Coil Assisted Flow Diverter device, designed to treat intracranial aneurysms. Neqstent™ is designed to treat a range of aneurysm morphologies including wide-necked bifurcation and bifurcation aneurysms. Neqstent™ is an adjunctive intrasaccular flow diverter device that provides stable aneurysm neck coverage for the placement of embolization coils within the sac and long-term occlusion of the aneurysm.

Right M1 occlusion with STAT technique

SNIS recommendations for neurointerventional patients treatment during COVID-19

Check out the recommendations published by the Society of NeuroInterventional Surgery for the care of emergent neurointerventional patients in the setting of COVID-19.

Covid-19: SNIS recommendations

Interventional Neuroradiology during the COVID-19 pandemic